mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline
Kseniya Obraztsova(Lung Institute), Vera P. Krymskaya(University of Pennsylvania), Jeremy Katzen(Translational Therapeutics (United States)), Edward Cantu(Hospital of the University of Pennsylvania), Michael F. Beers(University of Pennsylvania), Jilly F. Evans(Merck & Co., Inc., Rahway, NJ, USA (United States)), David B. Frank(Children's Hospital of Philadelphia), Annette Robichaud(The Quebec Population Health Research Network), Aravind Sivakumar(University of Pennsylvania), Elena N. Atochina‐Vasserman(University of Pennsylvania), Meghan C. Kopp(University of Pennsylvania), Apoorva Babu(University of Pennsylvania), Shanru Li(University of Pennsylvania), Maria C. Basil(Boston University), Edward E. Morrisey(Penn Center for AIDS Research), Andrei I. Gritsiuta(University of Pennsylvania), Susan M. Lin(Hospital of the University of Pennsylvania), Michael P. Morley(University of Pennsylvania), Alexander R. Mukhitov(University of Pennsylvania), Justine Carl(University of Pennsylvania), Ryan W. Rue(University of Pennsylvania)
Cited by 58
Related Papers
Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
|Cell|1996|2.4k
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
|Nature Communications|2020|924
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
|Nature reviews. Immunology|2015|758